Transcriptional Targeting for Ovarian Cancer Gene Therapy

This publication has 81 references indexed in Scilit:

• Gene therapy for cancer
  European Journal Of Cancer, 1999
• Analysis of Telomerase Activity in Ovarian Cystadenomas, Low-Malignant-Potential Tumors, and Invasive Carcinomas
  Gynecologic Oncology, 1999
• In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines
  American Journal of Obstetrics and Gynecology, 1997
• In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine
  Human Gene Therapy, 1995
• Clinical evaluations of a new ovarian cancer marker, COX‐1
  International Journal of Gynecology & Obstetrics, 1995
• Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  JNCI Journal of the National Cancer Institute, 1995
• Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Ovarian Cancer: A Pilot Trial. M.D. Anderson Cancer Center, Houston, Texas
  Human Gene Therapy, 1994
• Isolation of an X-Ray-Responsive Element in the Promoter Region of Tissue-Type Plasmingoen Activator: Potential Uses of X-Ray-Responsive Elements for Gene Therapy
  Radiation Research, 1994
• Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies
  Cancer Immunology, Immunotherapy, 1993
• Inhibin as a Marker for Granulosa-Cell Tumors
  New England Journal of Medicine, 1989